Smooth muscle 22.alpha. promoter, gene transfer vectors containi

Details Smooth muscle 22.alpha. promoter, gene transfer vectors containi Smooth muscle 22.alpha. promoter, gene transfer vectors containi

1998-07-28

2000-01-18

Campell, Bruce R.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

4353201, 514 44, 536 231, 536 235, 536 241, 536 245, A61K 4800

Patent

active

060157119

ABSTRACT:
The present invention relates to isolated DNA molecules encoding the murine SM22.alpha. promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells.

REFERENCES:
patent: 5266488 (1993-11-01), Ordahl et al.
patent: 5304489 (1994-04-01), Rosen
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5352595 (1994-10-01), Tapscott et al.
Shanahan et al, Circulation Research, 73(1):193-204 (1993).
Lees-Miller et al, J. Biol. Chem., 262(7):2988-2991 (1987).
Duband et al, Differentiation, 55:1-11 (1993).
Ayme-Southgate et al, J. Cell Biol., 108:521-531 (1989).
Lees-Miller et al, Biochem. J., 224:705-709 (1987).
Gimona et al, Eur. J. Biochem., 205:1067-1075 (1992).
Applegate et al, J. Biol. Chem., 269(14):10683-10690 (1994).
Thweatt et al, Biochem. and Biophys. Res. Comm., 187(1):1-7 (1992).
Nishida et al, Biochem. International, 23(4):663-668 (1991).
Pearlstone et al, J. Biol. Chem., 262(13):5985-5991 (1987).
Solway et al, J. Biol. Chem., 270:13460-13469 (Jun. 2, 1995).
Genbank Accession No. L41154, May 1, 1995.
Genbank Accession No. L41161, May 2, 1995.
Genbank Accession No. L41169, May 2, 1995.
Genbank Accession No. L41170, May 2, 1995.
Miano et al, Circulation, 90(No. 4, Part 2):I-245, Abstract No. 1315 (Oct. 1994).
Li Li et al, "Expression of SM22.alpha. Correlates with the Development of Cardiovascular System During Mouse Embryogenesis", Abstract No. P73 and Poster, Scientific Conference on the Molecular, Cellular, and Functional Aspects of Cardiovascular Development, New Orleans, Louisiana (Mar. 23-26, 1995).
Hanley et al, BioTechniques, 10(1):56 (1991).
Chang et al, Science, Abstract, 267(5197):518-522 (1995).
Werner et al, EMBO J., Abstract, 12(7):2635-2643 (1993).
Kemp et al, Biochem. J., 310:1037-1043 (1995).
Nishida et al, Gene, 130:297-302 (1993).
Sambrook et al, "Molecular Cloning: A Laboratory Manual", 2nd Ed., CHS Press, pp. 8.46-8.47, 9.2-9.3 and 16.56-16.57 (1989).
Sessa et al, J. of Biol. Chem., 267:15274-15276 (1992).
Simons et al, Nature, 359:67-70 (1992).
Miller et al, FASEB J., 9:190-199 (1995).
Mossler et al, Development, 122:2415-2425 (1996).
Latimer et al. Highly conserved upstream regions of the alpha1-antitrypsin gene in two mouse species govern liver-specific expression by different mechanisms. Molecular and Cellular Biology 10:760-769, Jun. 1990.
Eck and Wilson. Gene based therapy. In Goodman and Gilman's The pharmacological basis of therapeutics, 9th edition. McGraw-Hill. New York, 1995.
Orkin and Motulsky. Report and recommendation of the panel to asses the NIH investment in research on gene therapy, Dec. 1995.
Solway et al. Structure and expression of a smooth muscle cell-specific gene, SM22alpha. Journal of Biological Chemistry 270:13460-13469, Jun. 1995.
Chang et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinablastoma gene product. Science 267: 518-522, Jan. 1995.
Yokoyama et al. Transcriptional control of the endogenous MYC protooncogene by antisense RNA. Proc. Natl. Acad. Sci. USA 84: 7363-7367, Nov. 1987.
Bennett et al. Inhibition of vasscular smooth muscle cell proliferation in veitro and in vivo by c-myc antisense oligodeoxynucleotides. Journal of Clinical Investigation 93:820-828, Feb. 1994.
Miller and Vile. Targeted vectors for gene therapy. FASEB Journal 9: 190-199, Feb. 1995.

Affiliated with

Also associated with

Rating

Smooth muscle 22.alpha. promoter, gene transfer vectors containi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Smooth muscle 22.alpha. promoter, gene transfer vectors containi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Smooth muscle 22.alpha. promoter, gene transfer vectors containi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-562575